Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Overview of attention for article published in New England Journal of Medicine, March 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news: 10 news outlets
blogs: 2 blogs
twitter: 90 X users
patent: 12 patents
facebook: 7 Facebook pages

wikipedia: 1 Wikipedia page
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 8 clinical guideline sources

Readers on

mendeley: 488 Mendeley

So far, Altmetric has seen 10 public wall posts from 7 users.

Asociación Colombiana de Medicina Interna, 28 Apr 2017

Original Article: Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients http://nej.md/2mt4LCr #Cardiology pic.

Colorado Pharmacists Society, 22 Apr 2017

Time to talk about PCSK9 inhibitor issues stemming from SPIRE but first high risk patients and PCSK9 drugs (1/3) http://www.nejm.

ACCP Cardiology PRN, 21 Apr 2017

Time to talk about PCSK9 inhibitor issues stemming from SPIRE but first high risk patients and PCSK9 drugs (1/3) http://www.nejm.

Centre for Evidence-based Medicine, 20 Apr 2017

http://www.nejm.org/doi/full/10.1056/NEJMoa1701488?query=TOC

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 6 additional Facebook posts.